Lead, Global Market Access

At Astellas, we strive to become a cutting-edge, value-driven life science innovator. This means working at the forefront of healthcare change to turn innovative science into VALUE for patients.

**What sets us apart is our focus on patients, our pioneering innovation, our collaborative culture, and the passion of our talented people.**

Making a positive impact on patients’ lives is the purpose behind everything we do. At Astellas, we are relentless in our pursuit of scientific progress and in tackling unmet medical needs, demonstrated by our legacy in oncology, overactive bladder and transplant and our impressive pipeline in women's health, blindness and regeneration, genetic regulation, immuno-oncology, mitochondria and targeted protein degradation.

**About Us**:
We are a global pharmaceutical company headquartered in Japan, with a team of more than 14,000 managing operations in approximately 70 countries around the world. We are in the Top 30 global biopharma company based on global revenues and are predicted to be one of the Top 10 Cancer Drug Makers of 2024 by Fierce Pharma.

**In Canada, we are growing to meet the exciting opportunities realized by our legacy brands and rich pipeline of innovative treatments.**

From the first day in role, everyone at Astellas has a responsibility for creating a brighter future for patients around the world. We nurture exceptional relationships with our employees to allow them to thrive, foster innovation, and deliver exceptional business results. We work to create a culture where our people feel empowered to pursue brave ideas and ambitious outcomes, to have the confidence to be accountable for a higher standard of performance and embody a competitive and solutions-oriented mindset.

**Our expertise, science and technology make us a pharma company. Our open and diverse culture is what makes us uniquely Astellas.**

Astellas Pharma Canada (APCA) is currently searching for a Lead, Global Market Access and Pricing, Oncology.

**Description**

The Global Market Access & Pricing Lead Oncology (VYLOY) is responsible for the world-wide market access and pricing strategy for the product. They are the key interface between the GAVP team and all cross functional partners, co-creation markets and beyond. They have the final responsibility for the overall Market Access and Pricing Strategy - development, roll out and implementation, including LCM, across all co-creation markets and across the wider organization. The Global Market Access Lead is required to work closely not only with the AMT & GCT cross-functional membership, but also directly with all-in-scope markets to support and drive pricing and reimbursement. The Global Market Access Lead Oncology is responsible for bringing together complex payer requirements into a life cycle payer value proposition and tailored Market Access & pricing strategies to optimize asset value and support achievement of Global Brand Score Card.

**Essential Job Duties**

Market Access and Pricing Brand Strategy
- Develop and drive execution of the Global Market Access and Pricing Brand Strategy through leading a multi-disciplinary Value Access Strategy Team in co-creation of a best-in-industry value position strategy which optimizes product payer leverage points through tailored and where needed innovative payer solutions.
- Represent Global Market Access &VAST perspective on payer needs as a core member of the Asset Maximization Team and Global Co-creation Team and impact Commercialization and evidence generation strategy in alignment with AMT co-leads to optimize brand value under consideration of reimbursement & pricing requirements and dynamics
- Lead the development and implementation of innovative pricing and reimbursement strategies using value-based methodologies that both capture optimal product value and support commercial strategy/product positioning for new indications
- Generate payer insights in relation to the product and dynamics impacting the product’s Market Access & Pricing prospects, analyze and develop market access and pricing strategy accordingly
- Develop and Drive Access and pricing strategy which supports achievement of Global BSC
- Deep understanding of all key global payer healthcare systems and HTAs

Global Payer Value Proposition
- Develop global value story and global value dossier based on insights collated, identify areas needing Medical Affairs, Value Evidence, Clinical Development and Statistics input and seek analyses and evidence generation accordingly

Evidence Generation Strategies
- Define the payer value requirements for the evidence generation plan throughout the lifecycle of the product, identify areas needing MA & VE input and execution in evidence generation plans and establish alignment with critical functions such as Regulatory, Clinical Development, Stats team and the co-creation and sub co-creation Markets and endorsement by senior leadership

Leading within a Matrix Organization
- Driving hori